“G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients” (2025) European Journal of Pharmaceutical Research, 5(1), pp. 6–15. doi:10.24018/ejpharma.2025.5.1.85.